RESEARCH-USE BIOSIMILAR ANTIBODY
Figitumumab
Monoclonal antibody · IgG2
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM.
TARGETIGF1R
YMonoclonal antibody
CATALOGSC-BS-535
CATALOG NUMBERSC-BS-535
MOLECULAR WEIGHTApprox. 144.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM.
Figitumumab is a recombinant research-use antibody directed against IGF1R.